Detalhe da pesquisa
1.
Chromothripsis as a pathogenic driver of multiple myeloma.
Semin Cell Dev Biol
; 123: 115-123, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958284
2.
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
Am J Hematol
; 98(2): 264-271, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588407
3.
Differential RNA splicing as a potentially important driver mechanism in multiple myeloma.
Haematologica
; 106(3): 736-745, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079689
4.
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
Eur J Haematol
; 106(2): 230-240, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107092
5.
TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use.
BMC Bioinformatics
; 21(1): 144, 2020 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293247
6.
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.
Br J Haematol
; 187(3): 319-327, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218679
7.
Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis.
Mod Pathol
; 31(3): 452-462, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052601
8.
Multiparameter flow cytometry in plasma cell disorders: when in doubt, go with the flow.
Br J Haematol
; 196(5): 1132-1133, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825361
9.
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.
Blood
; 125(5): 831-40, 2015 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428216
10.
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Haematologica
; 102(9): 1617-1625, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550183
11.
Bartonellosis mimicking post-transplant lymphoproliferative diseases.
Nephrol Dial Transplant
; 37(3): 599-601, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791417
12.
High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse.
Br J Haematol
; 195(2): 283-286, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244996
13.
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Eur J Haematol
; 107(3): 370-373, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018260
14.
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.
Genes Chromosomes Cancer
; 54(2): 91-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25287954
15.
Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population.
Br J Haematol
; 188(3): e24-e27, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742668
16.
The genomic landscape of plasma cells in systemic light chain amyloidosis.
Blood
; 132(26): 2775-2777, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446495
17.
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Cancer
; 120(24): 3952-7, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25116271
18.
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.
Br J Haematol
; 167(4): 506-13, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25160558
19.
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma.
Clin Cancer Res
; 30(3): 575-585, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939148
20.
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
J Clin Oncol
; 42(11): 1229-1240, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194610